Skip to main content

triamcinolone acetonide

Generic: TRIAMCINOLONE ACETONIDE·Brand: ALLERNAZE, ARISTOCORT, ARISTOCORT A, ARISTOGEL, AZMACORT, FLUTEX, KENALOG, KENALOG IN ORABASE, KENALOG-10, KENALOG-40, KENALOG-80, KENALOG-H, NASACORT, NASACORT ALLERGY 24 HOUR, NASACORT HFA, ORALONE, TRIACET, TRIACORT, TRIAMCINOLONE ACETONIDE, TRIANEX, TRIATEX, TRIDERM, TRIESENCE, TRIVARIS, TRYMEX, XIPERE, ZILRETTA

triamcinolone acetonide: developed by 1 company · 5 clinical trials tracked.

triamcinolone acetonide evidence translation

What we can confirm

What it means

Source-backed records connect triamcinolone acetonide to CLSDQ; that link alone does not prove the drug works.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

How could triamcinolone acetonide → CLSDQ affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 0 study sponsors

Related indications

Macular edema associated with uveitisAtopic Dermatitis

Study sponsors

No additional listed-company sponsor is linked.

Development Pipeline (1)
CompanyPhase
Clearside Biomedical, Inc. (CLSDQ)
Macular edema associated with uveitis
Approved
Clinical Trials (5)

The Effect of Topical Triamcinolone Acetonide Application on Wound Healing in the Palatal Donor Site Following Free Gingival Graft Surgery

NCT07409571·N/A·CLSDQ
Recruiting

Primary endpoint: Oral Health-Related Quality of Life

InterventionalRandomizeddouble34 targetStarted 2026-01Completion 2026-031 site · Turkey (Türkiye)Kahramanmaras Sutcu Imam University

Comparison of the Outcome of Treatment of Intralesional Triamcinolone Acetonide With Intralesional Verapamil Hydrochloride in Patients Presenting With Keloid at Tertiary Care Hospital, Bahawalpur.

NCT07420166·N/A·CLSDQ
Completed

Primary endpoint: Scar assessment

InterventionalRandomizedopen60 enrolledStarted 2025-01Completion 2025-061 site · PakistanMuhammad Aamir Latif

Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis: a Randomized Controlled Superiority Trial

NCT06176248·N/A·CLSDQ
Recruiting

Primary endpoint: Constant score

InterventionalRandomizeddouble62 targetStarted 2024-10Completion 2027-031 site · FranceCHU de Reims

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis (ADRN-12)

NCT05436535·Phase 4·CLSDQ
Completed

Primary endpoint: Mild (EASI ≤ 7) vs. moderate-to-severe (EASI > 7) AD severity between type 2-high vs. type 2-low endotype from non-lesional skin transcriptome in the dupilumab-naïve AD adults and children.

Interventionalopen433 enrolledStarted 2022-11Completion 2025-1010 sites · United StatesNational Institute of Allergy and Infectious Diseases (NIAID)

Symptom Clusters in Children With Exacerbation-prone Asthma

NCT04002362·Phase 2
Completed

Primary endpoint: Change in Asthma Control Questionnaire (ACQ) Score

Interventionalopen68 enrolledStarted 2019-11Completion 2025-122 sites · United StatesEmory University

Frequently asked questions

Who is developing triamcinolone acetonide?

triamcinolone acetonide is being developed by Clearside Biomedical, Inc..

How many clinical trials involve triamcinolone acetonide?

BioSniper tracks 5 clinical trials involving triamcinolone acetonide.